Jesper Høiland retires as chief commercial officer of Ascendis Pharma

Former executive vice president of Novo Nordisk, US, Jesper Høiland has decided to step down from his role as global chief commercial officer at Ascendis Pharma.
Jesper Høiland, outgoing global chief commercial officer of Ascendis Pharma | Photo: Radius Health / PR
Jesper Høiland, outgoing global chief commercial officer of Ascendis Pharma | Photo: Radius Health / PR
by christopher due karlsson, translated by daniel pedersen

Danish biotech firm Ascendis Pharma, which is publicly listed in the US, has announced that Jesper Høiland, a former long-standing executive at Novo Nordisk in the US, is retiring from his role as global chief commercial officer, the firm reports on Monday.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
Must be at least 8 characters, including three of: Uppercase, lowercase, numbers, symbols
Must contain at least 2 characters
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Share article

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

Newsletter terms

Front page now

Further reading